Additionally, the expression level of BUB3 was significantly higher in cases of cervical, bladder, head, brain, colorectal, central nervous system, gastric, head, blood, and liver cancers, as well as melanomas and sarcomas. This evidence concerns the gene BUB3 and liver cancer.